There were 5.9 million documented cases of nonsurgical facial rejuvenation procedures, specifically soft tissue fillers and botulinum toxin in 2013 — and a 5,680% increase in injectables in the past 25 years. The numbers are only expected to grow. But how well do you know who this population of “minimally invasive” patients are?
In their study, “Motivations for Seeking Minimally Invasive Cosmetic Procedures in an Academic Outpatient Setting,” (Aesth Surg J. 2015,Vol35(8)1014–1020), authors Joseph F. Sobanko, M.D., Anthony J. Taglienti, M.D., et. al., cite this exponential rise of minimally invasive procedures, combined with the limited amount of patient data gathered from research in this area. Their goal: to better define and understand who those patients are and what’s driving their motivations.
Jointly, they carried out a prospective cohort study between the Division of Plastic Surgery and the Department of Dermatology (Hospital of the University of Pennsylvania) between September 1, 2011 and December 1, 2014. They invited patients to participate who were between the ages of 25 and 70 and who visited the Department of Dermatology or the Division of Plastic Surgery for minimally invasive facial rejuvenation procedures, defined as botulinum toxin injection or soft tissue filler injection. They excluded patients with prior facial cosmetic or reconstructive procedures, craniofacial abnormalities or facial scarring.
Demographic Snapshot:
Read more at Cosmetic Surgery Times. 
 
Only a few days left to register! How to Successfully Open a Medical Spa--Northeast: May 16-17, 2016
Southeast Medical Spa Regulatory Workshop: June 6, 2016
How to Successfully Open a Medical Spa--Northwest: September 19-20, 2016
How to Successfully Open a Medical Spa--Texas: November 6-7, 2016
Southwest Medical Spa Regulatory Workshop: December 5, 2016